Literature DB >> 540343

Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.

S Kobayashi, T Fukuda, I Imada, M Fujino, I Azuma, Y Yamamura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 540343     DOI: 10.1248/cpb.27.3193

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  7 in total

1.  Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.

Authors:  T W Chan; A Becker
Journal:  Pharm Res       Date:  1988-08       Impact factor: 4.200

2.  Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

Authors:  I Saiki; Y Tanio; M Yamawaki; M Uemiya; S Kobayashi; T Fukuda; H Yukimasa; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

3.  Effect of quinonyl-N-acetyl muramyl dipeptide on immune responses in tumor-bearing mice.

Authors:  I Saiki; Y Tanio; K I Yamamoto; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Activation of macrophages by quinonyl-N-acetylmuramyl dipeptide.

Authors:  I Saiki; Y Tokushima; K Nishimura; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

5.  Stimulation of chemiluminescence by synthetic muramyl dipeptide and analogs.

Authors:  K N Masihi; I Azuma; W Brehmer; W Lange
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

6.  Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

Authors:  K N Masihi; W Brehmer; I Azuma; W Lange; S Müller
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

Review 7.  Harnessing the untapped potential of nucleotide-binding oligomerization domain ligands for cancer immunotherapy.

Authors:  Sanja Nabergoj; Irena Mlinarič-Raščan; Žiga Jakopin
Journal:  Med Res Rev       Date:  2018-12-13       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.